Besponsa

Besponsa

Basic Prescribing Info
Contents
Inotuzumab ozogamicin
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FB01 - inotuzumab ozogamicin ; Belongs to the class of CD22 (Clusters of Differentiation 22) inhibitors. Used in the treatment of cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement